Mixing academic points of view can turn up some fascinating results, and numbers-oriented Yale graduate school researchers have turned their sights on medication use in America, to great effect.
A study underway by the Yale School of Management shows disturbingly varied patterns of use of popular medications like anti-depressants, anti-psychotics and stimulants.
Analyzing patterns of prescription use finds disturbing patterns of high use of anti-depressants, for one example. This band of high prescribing is centered on Tennessee. (Source: Yale School of Management)
A band of heavy use of these drugs cuts from Texas in a curve up through Appalachia, with heaviest use of all three drug categories centered on Tennessee. You can see some of the patterns in the map here, and follow this link to more fascinating maps.
Colorado and much of the West come out very well, if you assume that less use of drugs is better.
The most intense clusters across the U.S. showed people 77 percent more likely to have a stimulant prescription, 46 percent more likely to have an anti-depressant, and 42 percent more likely to have an anti-psychotic than people living outside those clusters.
Yale researchers Marissa King and Connor Essick said the numbers correlate closely with patients having local access to health care, and geographic patterns of where pharmaceutical companies spend their money on doctor “education” and marketing. In other words, if you live close enough to a doctor who is getting wined and dined by the big drug companies, you are much, much more likely to get these pills. That seems intuitive, of course, but it’s nice to have real numbers to back up what we’ve all been suspecting.
Culling of pharmacy statistics could also help the FDA and CDC attack overuse of opioid painkillers, which is epidemic across America.
Some local highlights, or lowlights as the case may be: Alexandria, Virginia, saw 40 percent of its residents got an anti-depressant (proximity to “fiscal cliff” nonsense?), compared to a mean of 10 percent of residents nationally. Florida lived up to its reputation as an “interesting” state with a rate of anti-psychotic use of 4.6 percent in Gainesville, compared to 0.8 percent nationally.
Zeroing in on the maps can be telling, especially in areas with small towns or rural health care; in some of these highlighted regions, there may be only a couple of prescribing physicians, meaning overuse can be traced fairly directly to individual doctors or practices.
The data is based on zip code analysis of prescriptions written for about 60 percent of U.S. patients.
Their “Geography of Anti-depressant, Anti-psychotic and Stimulant Utilization in the United States will be published in the journal “Health & Place.”